Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
As the claims evolve, it will be interesting to see if liability will be allocated differently given the intended use of the drug
declares having received consulting honoraria from Altimmune, Amgen, Esperion Therapeutics, Merck, MJH Life Sciences, Novartis and Novo Nordisk and having received a grant, paid to his institution, from Boehringer Ingelheim
Nominal calculations may be performed only after those values are independently established
US$ 24.49
US$ 21.88
US$ 28.95
US$ 25.60
US$ 26.89
US$ 20.98
US$ 21.11
US$ 27.87
US$ 28.12
US$ 24.28
US$ 29.64
US$ 28.49
US$ 21.14
US$ 25.49
US$ 21.60
